HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

NeurologyLive® Friday 5 — June 24, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 24, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Multiple Sclerosis DMT Waste Is Staggering, New Study Shows

More than $5.2 million in new, unused DMTs were collected from patients with MS over the course of 1 year—from only 1 neuroimmunologist. Watching the phenomenon first-hand, investigators led by Darin T. Okuda, MD, set out to quantify just how much DMT waste was occurring and why.

2: Achieving Greater Diversity in Dementia Research: A Call to Action

In the June issue of NeurologyLive®, guest editor-in-chief R. Scott Turner, MD, PhD, writes that achieving greater diversity in study populations is a focus of increasing scrutiny, priority, and funding in all medical research, including studies enrolling individuals on the continuum of prodromal Alzheimer disease, mild cognitive impairment, and Alzheimer disease.

3: NeuroVoices: Ruth Benca, MD, PhD, on the Importance of Maintaining Quality Sleep and Lowering Alzheimer Disease Risk

The professor and chair of Psychiatry & Human Behavior at Wake Forest School of Medicine discussed the major talking points regarding sleep quality, sleep disorders, and late-life neurocognitive issues.

4: Improving Post-Stroke Rehabilitation Through Primseq Digital Tool: Heidi Schambra, MD

The associate professor at the North Carolina Agricultural and Technical State University discussed a newfound initiative that helps encourage more professionals in multiple sclerosis and across the breadth of neurology.

5: The ATMRD Congress and Importance of Accessibility as a Clinician: Jill Farmer, DO, MPH

The director of the Parkinson’s Disease and Movement Disorder Program at Global Neuroscience Institute spoke about her time at the 2022 ATMRD Congress and how successful communication between patients and providers is rooted in accessibility.